Peripheral Arterial Disease in Patients Presenting with Acute Coronary Syndrome in Six Middle Eastern Countries

Abstract EN

To describe prevalence and impact of peripheral arterial disease (PAD) in patients with acute coronary syndrome (ACS), data were collected over 5 months from 6 Middle Eastern countries.

Patients were divided into 2 groups (with and without PAD).

Out of 6705 consecutive ACS patients, PAD was reported in 177 patients.

In comparison to non-PAD, PAD patients were older and more likely to have cardiovascular risk factors.

They were more likely to have high Killip class, high GRACE risk score, and non-ST elevation ACS (NSTEACS) at presentation.

Thrombolytics, antiplatelet use, and coronary intervention were comparable in both groups.

When presented with ST-elevation myocardial infarction (STEMI), patients with PAD had worse outcomes, while in NSTEACS; PAD was associated with higher rate of heart failure in comparison to non-PAD patients.

In diabetics, PAD was associated with 2-fold increase in mortality when compared to non-PAD (P=0.028).

After adjustment, PAD was associated with high mortality in STEMI (adjusted OR 2.6; 95% CI 1.23–5.65, P=0.01).

Prevalence of PAD in ACS in the Gulf region is low.

Patients with PAD and ACS constitute a high risk group and require more attention.

PAD in patients with STEMI is an independent predictor of in-hospital death.